Movatterモバイル変換


[0]ホーム

URL:


Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
Thehttps:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

NIH NLM Logo
Log inShow account info
Access keysNCBI HomepageMyNCBI HomepageMain ContentMain Navigation
pubmed logo
Advanced Clipboard
User Guide

Full text links

Nature Publishing Group full text link Nature Publishing Group Free PMC article
Full text links

Actions

Randomized Controlled Trial
.2014 Sep;39(10):2366-75.
doi: 10.1038/npp.2014.84. Epub 2014 Apr 9.

Role of dopamine D2 receptors in human reinforcement learning

Affiliations
Randomized Controlled Trial

Role of dopamine D2 receptors in human reinforcement learning

Christoph Eisenegger et al. Neuropsychopharmacology.2014 Sep.

Abstract

Influential neurocomputational models emphasize dopamine (DA) as an electrophysiological and neurochemical correlate of reinforcement learning. However, evidence of a specific causal role of DA receptors in learning has been less forthcoming, especially in humans. Here we combine, in a between-subjects design, administration of a high dose of the selective DA D2/3-receptor antagonist sulpiride with genetic analysis of the DA D2 receptor in a behavioral study of reinforcement learning in a sample of 78 healthy male volunteers. In contrast to predictions of prevailing models emphasizing DA's pivotal role in learning via prediction errors, we found that sulpiride did not disrupt learning, but rather induced profound impairments in choice performance. The disruption was selective for stimuli indicating reward, whereas loss avoidance performance was unaffected. Effects were driven by volunteers with higher serum levels of the drug, and in those with genetically determined lower density of striatal DA D2 receptors. This is the clearest demonstration to date for a causal modulatory role of the DA D2 receptor in choice performance that might be distinct from learning. Our findings challenge current reward prediction error models of reinforcement learning, and suggest that classical animal models emphasizing a role of postsynaptic DA D2 receptors in motivational aspects of reinforcement learning may apply to humans as well.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Sulpiride effects on reinforcement learning. The learning curves depict the ratio of volunteers that chose the ‘correct' stimulus in the gain domain (upper graph, solid lines), and the ‘incorrect' stimulus in the loss domain (lower graph, dashed lines). In the gain domain, the ‘correct' stimulus is associated with a probability of 0.75 of winning £1, whereas in the loss domain the ‘incorrect' stimulus is associated with a probability of 0.75 of losing £1. (a) Sulpiride (red) compared with placebo (blue) induces behavioral impairments in the gain domain after learning has plateaued (Mann–Whitney test,p=0.016,n=76). (b) Sulpiride group divided by serum values through median split. Higher serum levels (red) relate to more prominent impairments in the gain domain when compared with volunteers with lower serum levels (blue, Mann–Whitney test,p=0.031,n=39).
Figure 2
Figure 2
Parameter estimates of the Q-learning model across drug, serum value and genotype groups, separately for the gain and loss domain. (a) Temperature parameterβgain is significantly higher in the sulpiride group (57% increase compared with the placebo,p=0.005), but the learning rateαgain is not affected, and there are no effects in the loss domain (αloss,βloss). (b) Higher sulpiride serum values selectively affect the temperature parameterβgain (183% increase in high compared with low serum values,p=0.001), with no effects on eitherαgain,αloss orβloss. (c) Pronounced sulpiride effects onβgain are observed in A1+ genotype carriers (211% increase following sulpiride compared with placebo administration,p<0.001), but not in A1− genotype carriers.
Figure 3
Figure 3
Response latencies over trials. (a) Whereas response latencies decrease over trials in both groups, volunteers in the sulpiride (red) compared with the placebo (blue) group show higher response latencies in the gain domain in the plateau phase of learning (t-test,p=0.044,n=76). (b) Response latencies in the loss domain are higher than in the gain domain, and there is no significant difference between the sulpiride group (red) and the placebo group in the loss domain (blue).
Figure 4
Figure 4
Pharmacogenetic interaction of sulpiride and DA D2 receptor Taq1A polymorphism on reinforcement learning. (a) Volunteers with a genetically determined reduction in DA D2 receptor density (A1+ allele carriers) show behavioral impairments during reinforcement learning following sulpiride (red) compared with placebo (blue) administration in the gain domain (upper graph, solid lines, Mann–Whitney test,p=0.048,n=38), but not in the loss domain (lower graph, dashed lines). (b) Sulpiride (red) compared with placebo (blue) has no significant effect in either the gain (upper graph, solid lines) or the loss (lower graph, dashed lines) domain in volunteers who carry the common variant (A1−) of the polymorphism.
See this image and copyright information in PMC

References

    1. Ahlenius S, Engel J, Zoller M. Effects of apomorphine and haloperidol on exploratory-behavior and latent learning in mice. Phys Psychol. 1977;5:290–294.
    1. Bai JS, Perron P. Estimating and testing linear models with multiple structural changes. Econometrica. 1998;66:47–78.
    1. Bardgett ME, Depenbrock M, Downs N, Points M, Green L. Dopamine modulates effort-based decision making in rats. Behav Neurosci. 2009;123:242–251. - PMC - PubMed
    1. Bayer HM, Glimcher PW. Midbrain dopamine neurons encode a quantitative reward prediction error signal. Neuron. 2005;47:129–141. - PMC - PubMed
    1. Beninger RJ, Phillips AG. The effects of pimozide during pairing on the transfer of classical conditioning to an operant discrimination. Pharmacol Biochem Behav. 1981;14:101–105. - PubMed

Publication types

MeSH terms

Substances

Grants and funding

LinkOut - more resources

Full text links
Nature Publishing Group full text link Nature Publishing Group Free PMC article
Cite
Send To

NCBI Literature Resources

MeSHPMCBookshelfDisclaimer

The PubMed wordmark and PubMed logo are registered trademarks of the U.S. Department of Health and Human Services (HHS). Unauthorized use of these marks is strictly prohibited.


[8]ページ先頭

©2009-2025 Movatter.jp